120 related articles for article (PubMed ID: 10842706)
1. AL 612, a glycosylated lambda light chain of subgroup I.
Nilsen T; Sletten K; Westermark P
Amyloid; 2000 Mar; 7(1):51-3. PubMed ID: 10842706
[No Abstract] [Full Text] [Related]
2. The amino acid sequence of the glycosylated amyloid immunoglobulin light chain protein AL MS.
Omtvedt LA; Husby G; Cornwell GG; Kyle RA; Sletten K
Scand J Immunol; 1997 May; 45(5):551-6. PubMed ID: 9160102
[TBL] [Abstract][Full Text] [Related]
3. Lambda III subgroup immunoglobulin light chains are precursor proteins of nodular pulmonary amyloidosis.
Miura K; Shirasawa H
Am J Clin Pathol; 1993 Nov; 100(5):561-6. PubMed ID: 8249896
[TBL] [Abstract][Full Text] [Related]
4. Characterization of renal amyloid derived from the variable region of the lambda light chain subgroup II.
Picken MM; Gallo G; Buxbaum J; Frangione B
Am J Pathol; 1986 Jul; 124(1):82-7. PubMed ID: 3089021
[TBL] [Abstract][Full Text] [Related]
5. Amyloid fibrils derived from V-region together with C-region fragments from a lambda II-immunoglobulin light chain (HAR).
Eulitz M; Linke R
Biol Chem Hoppe Seyler; 1985 Sep; 366(9):907-15. PubMed ID: 3935132
[TBL] [Abstract][Full Text] [Related]
6. The amino acid sequence of a glycosylated AL-chain from a patient with primary amyloidosis.
Myran T; Husby G; Kyle RA; Sletten K
Amyloid; 2004 Jun; 11(2):109-12. PubMed ID: 15478466
[TBL] [Abstract][Full Text] [Related]
7. The repertoire of λ light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44.
Perfetti V; Palladini G; Casarini S; Navazza V; Rognoni P; Obici L; Invernizzi R; Perlini S; Klersy C; Merlini G
Blood; 2012 Jan; 119(1):144-50. PubMed ID: 22067386
[TBL] [Abstract][Full Text] [Related]
8. Primary localized amyloidosis of the eyelid: two cases of immunoglobulin light chain-derived proteins, subtype lambda V respectively lambda VI.
Olsen KE; Sandgren O; Sletten K; Westermark P
Clin Exp Immunol; 1996 Nov; 106(2):362-6. PubMed ID: 8918586
[TBL] [Abstract][Full Text] [Related]
9. Demonstration and partial characterization of an atypical protein in the urine of a patient with primary amyloidosis.
Wille LE; Olsen E; Førre O; Sletten K; Jentoft H
Acta Med Scand; 1980; 208(3):177-82. PubMed ID: 6776783
[TBL] [Abstract][Full Text] [Related]
10. Partial amino acid sequence of an amyloid fibril protein from nodular primary cutaneous amyloidosis showing homology to lambda immunoglobulin light chain of variable subgroup III (a lambda III).
Kitajima Y; Hirata H; Kagawa Y; Yaoita H
J Invest Dermatol; 1990 Sep; 95(3):301-3. PubMed ID: 2117035
[TBL] [Abstract][Full Text] [Related]
11. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).
Husby G; Sletten K; Blumenkrantz N; Danielsen L
Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317
[TBL] [Abstract][Full Text] [Related]
12. Complete amino acid sequence determinations demonstrate identity of the urinary Bence Jones protein (BJP-DIA) and the amyloid fibril protein (AL-DIA) in a case of AL-amyloidosis.
Klafki HW; Kratzin HD; Pick AI; Eckart K; Karas M; Hilschmann N
Biochemistry; 1992 Mar; 31(12):3265-72. PubMed ID: 1554711
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of protein AA and immunoglobulin light-chain fragments in amyloid fibrils.
Westermark P; Natvig JB; Anders RF; Sletten K; Husby G
Scand J Immunol; 1976; 5(1-2):31-6. PubMed ID: 57640
[TBL] [Abstract][Full Text] [Related]
14. Complementary DNA sequence of human amyloidogenic immunoglobulin light-chain precursors.
Aucouturier P; Khamlichi AA; Preud'homme JL; Bauwens M; Touchard G; Cogné M
Biochem J; 1992 Jul; 285 ( Pt 1)(Pt 1):149-52. PubMed ID: 1379039
[TBL] [Abstract][Full Text] [Related]
15. Equine cutaneous amyloidosis derived from an immunoglobulin lambda-light chain. Immunohistochemical, immunochemical and chemical results.
Linke RP; Geisel O; Mann K
Biol Chem Hoppe Seyler; 1991 Sep; 372(9):835-43. PubMed ID: 1772596
[TBL] [Abstract][Full Text] [Related]
16. A novel approach for the purification and proteomic analysis of pathogenic immunoglobulin free light chains from serum.
Lavatelli F; Brambilla F; Valentini V; Rognoni P; Casarini S; Di Silvestre D; Perfetti V; Palladini G; Sarais G; Mauri P; Merlini G
Biochim Biophys Acta; 2011 Mar; 1814(3):409-19. PubMed ID: 21215335
[TBL] [Abstract][Full Text] [Related]
17. Effect of O-glycosylation on amyloid fibril formation of the variable domain in the Vλ6 light chain mutant Wil.
Abe Y; Shibata H; Oyama K; Ueda T
Int J Biol Macromol; 2021 Jan; 166():342-351. PubMed ID: 33127550
[TBL] [Abstract][Full Text] [Related]
18. Anti-lambda-light chain-peptide antibodies are suitable for the immunohistochemical classification of AL amyloid.
Kuçi H; Ebert MP; Röcken C
Histol Histopathol; 2007 Apr; 22(4):379-87. PubMed ID: 17290348
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Light Chain 6aJL2-R24G Amyloid Fiber Formation Associated with Light Chain Amyloidosis.
Pelaez-Aguilar AE; Rivillas-Acevedo L; French-Pacheco L; Valdes-Garcia G; Maya-Martinez R; Pastor N; Amero C
Biochemistry; 2015 Aug; 54(32):4978-86. PubMed ID: 26214579
[TBL] [Abstract][Full Text] [Related]
20. Formation of amyloid fibers by monomeric light chain variable domains.
Brumshtein B; Esswein SR; Landau M; Ryan CM; Whitelegge JP; Phillips ML; Cascio D; Sawaya MR; Eisenberg DS
J Biol Chem; 2014 Oct; 289(40):27513-25. PubMed ID: 25138218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
